C.R. Bard, Inc. (NYSE:BCR)
The Company is engaged in the design, manufacture, packaging, distribution and sale of medical, surgical, diagnostic and patient care devices.
- Quote
- Commentary
- Scorecard
- Historical Prices
- Chart
- Stats
- Ratios
- Earnings/Growth Rates
- Statements
- SEC Filings
Recs
whoodatstockhot
(85.53)
Submitted: 6/5/2013 8:07:29 AM :
Start Price:
$103.81
BCR Score:
+6.07
Sometimes, you need to invest in the best of the best.
Recs
Recs
Teacherman333
(35.99)
Submitted: 5/15/2013 1:46:05 PM :
Start Price:
$104.24
BCR Score:
+5.70
For reference point and to allow for comments by others. As of the end of March, 2013.
ROE 25.57%
Trailing PE 18.87
PB 4.53
Div yield 0.80%
Recs
JohnCLeven
(83.02)
Submitted: 4/22/2013 12:45:09 PM :
Start Price:
$98.24
BCR Score:
+7.03
BCR has been on my radar for a while. BCR exhibits many of the characteristics that I find appealing in a business including: high returns on capital and equity, consistent growth in earnings and free cash flows, share buybacks, and a solid balance sheet.
BCR has a solid position within the medical device industry, and I believe that probability is very high that BCR will continue to create significant value over the next 5-10 years, and probably much longer. At today’s 6.8% free cash flow yield, this high-quality business should outperform in the long run. I am also following Donald Yacktman, and valuemoneygreen, both of whom recently added BCR.
Long term pick.
Recs
st2p0
(87.82)
Submitted: 4/19/2013 1:10:07 PM :
Start Price:
$98.88
BCR Score:
+6.13
42.3, 32.8, 39.6
6M RP Down for 3 mnths & 3M RP offset in low level overlap
Risk is 12M RP can go a lot lower
Recs
DrGoldin
(98.82)
Submitted: 1/14/2013 12:24:36 AM :
Start Price:
$101.32
BCR Score:
-1.39
No pitch for C.R. Bard since 2011? They're profitable. They're CONSISTENTLY profitable. They're in a sector that can only improve. The price is reasonable. What's not to like?
Recs
p1a5244
(77.32)
Submitted: 9/23/2011 9:36:29 PM :
Start Price:
$85.24
BCR Score:
-13.45
9/26/11 Options Predictor Rank #19. P/C Ratio 0.029 and Call Sizzle 3.131.
Recs
MathMusic
(72.17)
Submitted: 8/11/2011 3:33:09 PM :
Start Price:
$90.16
BCR Score:
-15.66
HIGH DIVIDENDS AS BONDS PLUMMET
Recs
Recs
Roni13
(29.01)
Submitted: 5/16/2010 7:14:01 AM :
Start Price:
$81.37
BCR Score:
-7.84
too cheap for its growth and fantastic balance sheet
Recs
knudfool
(95.55)
Submitted: 11/19/2009 12:59:49 AM :
Start Price:
$79.55
BCR Score:
-9.43
Looks like a good value and the baby boomers could keep the fueling the growth.
Recs
woppi
(83.55)
Submitted: 10/5/2009 3:57:03 PM :
Start Price:
$74.76
BCR Score:
-9.79
Low debt, high profit margins for the industry (just under 20%) and a nice steady increase in Total Cash from Operations down through the years. Operating expenses have also risen over the same period, but not as much indicating that management have a good handle on things. I think the impact of the Obama plan is already built into the current price, so I don't expect a lift from that.
Recs
EruditeInvestor
(40.47)
Submitted: 10/1/2009 2:04:15 PM :
Start Price:
$75.74
BCR Score:
-12.15
This High Quality manufacturer of medical devices has a QVT Rating of 9.93
Recs
pchristoph
(23.86)
Submitted: 9/22/2009 1:47:52 PM :
Start Price:
$77.21
BCR Score:
-10.01
high roe, good debt position
Recs
jammin200
(72.03)
Submitted: 9/21/2009 6:02:25 PM :
Start Price:
$77.73
BCR Score:
-11.00
2/122 in Health Care Equipment -(70.4@B/A-)
Recs
pedromigz
(25.82)
Submitted: 9/4/2009 7:18:28 AM :
Start Price:
$78.27
BCR Score:
-22.28
BofD, z3, pt92, analrep
Recs
JDKeene
(98.90)
Submitted: 8/12/2009 1:01:32 PM :
Start Price:
$71.78
BCR Score:
-9.10
Ford Strong Buy, S&P (4 or 3 stars), Member of S&P 500
Recs
STORMSTOCKER
(< 20)
Submitted: 7/7/2009 3:29:26 PM :
Start Price:
$72.83
BCR Score:
-34.46
BABY BOOMERS ARE AGING AND THIS IS A MEDICAL SUPPLY COMPANY THAT HAS FOLLOWED THE GILLETTE MODEL.....USE IT, DISPOSE IT, REPLACE IT. HEART, UROLOGY, ETC.ETC.ETC.ETC.
Recs
pp12000
(46.46)
Submitted: 6/22/2009 1:48:04 AM :
Start Price:
$71.32
BCR Score:
-25.98
earnings, sales, PE, growth from Obama
Recs
mtinvest
(91.45)
Submitted: 4/30/2009 4:29:49 AM :
Start Price:
$69.16
BCR Score:
-27.45
One of the 52 S&P500 Dividend Aristocrats. Competitors include BAX and BSX. At 70$ BCR is not that cheap at all, but it's a quality company, which will do well in the long run and for the short term, when the current April bull run is over.
RSS Headlines
Fool UK
- Show Me:
-
Outperform
-
Underperform
-
All
- Sort by:
-
Author
-
Recs
-
Date
-
Member Rating
-
Results 1 - 20 of 32 : 1 2 Next »